|
Delayed
Bombay S.E.
01:00:50 12/03/2026 pm IST
|
5-day change
|
1st Jan Change
|
|
26,793.85 INR
|
-1.53%
|
 |
-2.90%
|
-7.83%
|
|
24/12 |
Abbott India Limited Announces Resignation of Ambati Venu as Director, Effective Close of Business Hours of December 31, 2025
|
CI
| |
25/11 |
Abbott India Limited Announces Executive Changes
|
CI
| |
24/25/24 |
Abbott India Limited Announces the Resignation of Munish Prashar, Plant Director - Goa and Cease to Be the Senior Management Personnel, Effective October 31, 2025
|
CI
| |
14/25/14 |
Abbott India Limited Approves Appointment of Kartik Rajendran as Managing Director, Effective from June 14, 2025
|
CI
| |
14/25/14 |
Abbott India Limited Approves Appointment of Kartik Rajendran as Director
|
CI
| |
07/25/07 |
Abbott India Says Swati Dalal Resigns As Managing Director
|
RE
| |
07/25/07 |
Abbott India Limited Announces Resignation of Swati Dalal as Managing Director, Effective June 13, 2025
|
CI
| |
07/25/07 |
Abbott India Limited Announces Resignation of Swati Dalal as Director and Key Managerial Personnel, Effective June 13, 2025
|
CI
| |
18/25/18 |
Abbott India Appoints Maithilee Mistry As CFO
|
RE
| |
18/25/18 |
Abbott India Limited Appoints Maithilee Mistry as the Chief Financial Officer, Effective May 6, 2025
|
CI
| |
18/25/18 |
Abbott India Limited Appoints Maithilee Mistry as the Key Managerial Personnel, Effective May 6, 2025
|
CI
| |
16/25/16 |
Abbott India Limited Announces the Resignation of Ms. Namita Shah - Associate Director -New Product Introduction and Therapy Area Strategy of the Company, Effective from April 15, 2025
|
CI
| |
11/25/11 |
SetPoint Medical Corporation amended terms of the transaction
|
CI
| |
01/25/01 |
Abbott India Limited Appoints Devesh Choudhari as Director - Finance, Effective April 1, 2025
|
CI
| |
26/25/26 |
Abbott India Limited Announces Resignation of Jyoti Saraph, Director Finance, with Effect from June 23, 2025
|
CI
| |
20/25/20 |
Abbott India Limited Announces Resignation of Namita Shah - Associate Director - New Product Introduction and Therapy Area Strategy, Effective April 15, 2025
|
CI
| |
05/25/05 |
Abbott India Limited Approves the Appointment of Harshraj Madan as Commercial Director - GI Business, Effective February 17, 2025
|
CI
| |
03/25/03 |
Abbott India Limited Announces Board Changes
|
CI
| |
21/25/21 |
Abbott India Limited Announces Kunal Chowdhury - Commercial Director - GI Businesses, to Serve Until January 31, 2025
|
CI
| |
16/25/16 |
Abbott India Limited Appoints Anuj Mehra as Commercial Director - Neurolife, Gennext and Vaccines, Effective February 1, 2025
|
CI
| |
03/25/03 |
Abbott India Limited Announces Change of Commercial Director
|
CI
| |
17/24/17 |
Abbott India's CFO Steps Down
|
MT
| |
16/24/16 |
Abbott India Limited Announces Resignation of Sridhar Kadangode as Whole Time Director and Director
|
CI
| |
16/24/16 |
Abbott India Limited Announces Resignation of Sridhar Kadangode as Chief Financial Officer, Effective from February 26, 2025
|
CI
| |
07/24/07 |
Abbott India Limited Appoints Mr. Sridhar Kadangode as an Additional Director and as the Whole Time Director of the Company
|
CI
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
